# Mondelēz International, Inc. clinical trials: 27 (2026)

ClinicalTrials.gov lists 27 trials with Mondelēz International, Inc. as lead sponsor, 1 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Mondelēz International, Inc.: 27 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/mondel-z-international-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 13, 2026 | NCT07408479 | Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal... | Mondelēz International, Inc. | Not applicable | Recruiting | Insulin Resistance | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408479) |
| January 28, 2026 | NCT07372482 | Evaluating the Impact of Fat and Sugar Replacer Blends on Gastrointestinal Tolerance in Biscuits | Mondelēz International, Inc. | Not applicable | Completed | Gastrointestinal Tolerance, Healthy Population | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07372482) |
| June 28, 2024 | NCT06479330 | Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate | Mondelēz International, Inc. | Not applicable | Completed | Gastrointestinal Tolerance, Healthy Population | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06479330) |
| April 24, 2023 | NCT05827198 | Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies | Mondelēz International, Inc. | Not applicable | Unknown | Gastrointestinal Tolerance, Healthy Population | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05827198) |
| April 3, 2023 | NCT05794100 | Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance | Mondelēz International, Inc. | Not applicable | Completed | Tolerance, Healthy Population | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05794100) |
| June 3, 2019 | NCT03971084 | Impact of Chewing Gum With CPP-ACP on Tooth Mineralisation in Situ | Mondelēz International, Inc. | Not applicable | Unknown | Tooth Demineralization | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03971084) |
| February 20, 2019 | NCT03847701 | Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients | Mondelēz International, Inc. | Not applicable | Completed | Type2 Diabetes | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03847701) |
| September 21, 2017 | NCT03289494 | Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients | Mondelēz International, Inc. | Not applicable | Completed | Type2 Diabetes | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03289494) |
| January 8, 2016 | NCT02650674 | Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products | Mondelēz International, Inc. | Not applicable | Completed | Metabolic Disorder | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02650674) |
| September 2, 2015 | NCT02538653 | Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone. | Mondelēz International, Inc. | Not applicable | Completed | Metabolic Disorder; Carbohydrate, Absorption, Intestine | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02538653) |
| September 2, 2015 | NCT02538640 | Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and GI Consumed Alone. | Mondelēz International, Inc. | Not applicable | Completed | Metabolism and Nutrition Disorders | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02538640) |
| December 23, 2014 | NCT02323542 | Plasma Glucose Kinetics and Cereal Product Content in Slowly Digestible Starch (SDS) in Healthy Volunteers | Mondelēz International, Inc. | Not applicable | Completed | Blood Glucose Kinetics | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02323542) |
| June 6, 2013 | NCT01870570 | Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers | Mondelēz International, Inc. | Not applicable | Completed | Glycaemia, Insulinemia | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01870570) |
| September 19, 2012 | NCT01687569 | Glycaemic Responses to Cracker Snacks | Mondelēz International, Inc. | Not applicable | Completed | Glycaemic Response Measurements | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01687569) |
| September 10, 2012 | NCT01682174 | Glycaemic Response to a Liquid Meal Tolerance Test | Mondelēz International, Inc. | Not applicable | Completed | Glycaemic Index, Glycaemic Response | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01682174) |
| August 24, 2012 | NCT01671878 | Glucose and Insulin Responses to Test Foods | Mondelēz International, Inc. | Not applicable | Completed | Glucose Response, Insulin Response | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01671878) |
| June 21, 2012 | NCT01625624 | Evaluating the Effects of Food Products on Energy and Performance | Mondelēz International, Inc. | Not applicable | Completed | Energy | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01625624) |
| March 6, 2012 | NCT01544816 | Evaluating the Effects of Snack Products on Energy | Mondelēz International, Inc. | Not applicable | Completed | Energy | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01544816) |
| February 22, 2012 | NCT01536860 | Glycemic Response Testing | Mondelēz International, Inc. | Not applicable | Completed | Glycemic Index, Glycemic Response | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01536860) |
| February 22, 2012 | NCT01536847 | Glycaemic Response Testing | Mondelēz International, Inc. | Not applicable | Completed | Glycaemic Index, Glycaemic Response | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01536847) |
| August 12, 2011 | NCT01415557 | Effect of Regular Consumption of Micronutrient Fortified Beverage on the Micronutrient Status of Indian Schoolchildren | Mondelēz International, Inc. | Not applicable | Completed | Healthy | 227 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01415557) |
| April 26, 2011 | NCT01341769 | Blood Glucose and Insulin Responses to Snack Food Products | Mondelēz International, Inc. | Not applicable | Withdrawn | Study Focus 1:Glycaemic Index, Study Focus 2:Glycaemic Response, Study Focus 3:Insulinemic Response | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01341769) |
| January 6, 2011 | NCT01271049 | An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths | Mondelēz International, Inc. | Not applicable | Terminated | Helminthiasis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01271049) |
| July 3, 2009 | NCT00932750 | Study of Coffee Mannooligosaccharides for Weight Management | Mondelēz International, Inc. | Not applicable | Completed | Obesity | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00932750) |
| July 3, 2009 | NCT00932516 | Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women | Mondelēz International, Inc. | Not applicable | Completed | Overweight | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00932516) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 27 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Unknown | 2 |
| Terminated | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 4 |
| Obesity | 3 |
| Weight Loss | 3 |
| Diabetes Mellitus | 2 |
| Overweight | 2 |
| Metabolic Diseases | 2 |
| Helminthiasis | 1 |
| Insulin Resistance | 1 |
| Tooth Demineralization | 1 |
| Nutrition Disorders | 1 |
| Shwachman-Diamond Syndrome | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
- [Electronic parts suppliers in the United States](https://specstream.ai/data/businesses/electronic-parts-suppliers/united-states)
- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Health insurance offices in the United States](https://specstream.ai/data/businesses/health-insurance-offices/united-states)
- [Aggregate suppliers in the United States](https://specstream.ai/data/businesses/aggregate-suppliers/united-states)
- [Machine shops in the United States](https://specstream.ai/data/businesses/machine-shops/united-states)
